Nonalcoholic Fatty Liver Disease: Current Global Burden
Semin Liver Dis 2022; 42: 401-412 DOI: 10.1055/a-1862-9088 The map and global disease burden of chronic liver diseases are markedly changing, with nonalcoholic fatty liver disease (NAFLD) becoming the most common cause of liver diseases coinciding with the current epidemics of obesity, type 2 diabetes, and metabolic syndrome. Understanding the incidence and prevalence of NAFLD is critical because of its linkage to a significant economic burden of hospitalization and changing patterns in consequences, such as liver transplantation. Moreover, the long-term average health care expenses of NAFLD patients have exceeded those of other liver diseases. To lessen the imminent burden of NAFLD, immediate actions to raise worldwide awareness and address metabolic risk factors are required. This review summarizes key data about the global disease burden of NAFLD, modifiable and nonmodifiable risk factors, and current preventive approaches. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Seminars in Liver Disease - Category: Gastroenterology Authors: El-Kassas, Mohamed Cabezas, Joaqu ín Coz, Paula Iruzubieta Zheng, Ming-Hua Arab, Juan Pablo Awad, Abeer Tags: Review Article Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemics | Epidemiology | Fatty Liver Disease (FLD) | Gastroenterology | Health Management | Liver | Liver Disease | Liver Transplant | Metabolic Syndrome | Middle East Health | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Transplants | Urology & Nephrology